SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/27/24 Aclaris Therapeutics, Inc. 10-K 12/31/23 91:11M Toppan Merrill Bridge/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 2.68M 2: EX-4.1 Instrument Defining the Rights of Security Holders HTML 38K 3: EX-10.15 Material Contract HTML 117K 4: EX-10.18 Material Contract HTML 86K 5: EX-10.22 Material Contract HTML 38K 6: EX-21.1 Subsidiaries List HTML 26K 7: EX-23.1 Consent of Expert or Counsel HTML 24K 11: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 45K Awarded Compensation 8: EX-31.1 Certification -- §302 - SOA'02 HTML 29K 9: EX-31.2 Certification -- §302 - SOA'02 HTML 28K 10: EX-32.1 Certification -- §906 - SOA'02 HTML 28K 17: R1 Document and Entity Information HTML 94K 18: R2 Consolidated Balance Sheets HTML 125K 19: R3 Consolidated Balance Sheets (Parenthetical) HTML 44K 20: R4 Consolidated Statements of Operations and HTML 118K Comprehensive Loss 21: R5 Consolidated Statements of Operations and HTML 27K Comprehensive Loss (Parenthetical) 22: R6 Consolidated Statements of Stockholders' Equity HTML 85K 23: R7 Consolidated Statements of Stockholders' Equity HTML 28K (Parenthetical) 24: R8 Consolidated Statements of Cash Flows HTML 101K 25: R9 Organization and Nature of Business HTML 33K 26: R10 Summary of Significant Accounting Policies HTML 72K 27: R11 Fair Value of Financial Assets and Liabilities HTML 191K 28: R12 Property and Equipment, Net HTML 44K 29: R13 Intangible Assets HTML 61K 30: R14 Accrued Expenses HTML 41K 31: R15 Debt HTML 31K 32: R16 Stockholders' Equity HTML 39K 33: R17 Stock-Based Awards HTML 166K 34: R18 Net Loss per Share HTML 64K 35: R19 Leases HTML 97K 36: R20 Income Taxes HTML 130K 37: R21 Agreements Related to Intellectual Property HTML 36K 38: R22 Retirement Savings Plan HTML 27K 39: R23 Restructuring Charges HTML 29K 40: R24 Segment Information HTML 132K 41: R25 Legal Proceedings HTML 28K 42: R26 Summary of Significant Accounting Policies HTML 121K (Policies) 43: R27 Fair Value of Financial Assets and Liabilities HTML 192K (Tables) 44: R28 Property and Equipment, Net (Tables) HTML 43K 45: R29 Intangible Assets (Tables) HTML 62K 46: R30 Accrued Expenses (Tables) HTML 40K 47: R31 Stock-Based Awards (Tables) HTML 164K 48: R32 Net Loss per Share (Tables) HTML 65K 49: R33 Leases (Tables) HTML 98K 50: R34 Income Taxes (Tables) HTML 128K 51: R35 Segment Information (Tables) HTML 127K 52: R36 Organization and Nature of Business (Details) HTML 31K 53: R37 Summary of Significant Accounting Policies HTML 36K (Details) 54: R38 Summary of Significant Accounting Policies - HTML 34K Property and Equipment (Details) 55: R39 Summary of Significant Accounting Policies - HTML 31K Intangible Assets (Details) 56: R40 Summary of Significant Accounting Policies - HTML 33K Stock-Based Compensation and Concentration of Credit Risk and of Significant Suppliers (Details) 57: R41 Summary of Significant Accounting Policies - HTML 26K Segments (Details) 58: R42 Fair Value of Financial Assets and Liabilities HTML 54K (Details) 59: R43 Fair Value of Financial Assets and Liabilities - HTML 64K By Type of Security (Details) 60: R44 Property and Equipment, Net (Details) HTML 44K 61: R45 Intangible Assets (Details) HTML 44K 62: R46 Intangible Assets - Future Amortization Expenses HTML 40K (Details) 63: R47 Accrued Expenses (Details) HTML 38K 64: R48 Debt (Details) HTML 43K 65: R49 Stockholders' Equity (Details) HTML 60K 66: R50 Stockholders' Equity - Other Offerings and ATM HTML 46K Facility (Details) 67: R51 Stock-Based Awards (Details) HTML 72K 68: R52 Stock-Based Awards - Option Activity (Details) HTML 84K 69: R53 Stock-Based Awards - RSUs (Details) HTML 51K 70: R54 Stock-Based Awards - Compensation (Details) HTML 45K 71: R55 Net Loss per Share (Details) HTML 56K 72: R56 Net Loss per Share - Anti-dilution (Details) HTML 32K 73: R57 Leases (Details) HTML 54K 74: R58 Leases - Lease Costs (Details) HTML 26K 75: R59 Leases - Supplemental Information Related to HTML 36K Operating Leases (Details) 76: R60 Leases - Future Maturities of Lease Liabilities HTML 43K (Details) 77: R61 Income Taxes - Rate Reconciliation (Details) HTML 64K 78: R62 Income Taxes - Deferred Assets and Liabilities, HTML 76K CFDs (Details) 79: R63 Income Taxes - Valuation Allowance and HTML 31K Unrecognized Tax Benefits (Details) 80: R64 Agreements Related to Intellectual Property HTML 53K (Details) 81: R65 Retirement Savings Plan (Details) HTML 28K 82: R66 Restructuring Charges (Details) HTML 43K 83: R67 Segment Information (Details) HTML 65K 84: R68 Legal Proceedings (Details) HTML 27K 85: R69 Pay vs Performance Disclosure HTML 36K 86: R70 Insider Trading Arrangements HTML 30K 88: XML IDEA XML File -- Filing Summary XML 155K 91: XML XBRL Instance -- acrs-20231231x10k_htm XML 2.56M 87: EXCEL IDEA Workbook of Financial Report Info XLSX 148K 13: EX-101.CAL XBRL Calculations -- acrs-20231231_cal XML 187K 14: EX-101.DEF XBRL Definitions -- acrs-20231231_def XML 602K 15: EX-101.LAB XBRL Labels -- acrs-20231231_lab XML 1.37M 16: EX-101.PRE XBRL Presentations -- acrs-20231231_pre XML 938K 12: EX-101.SCH XBRL Schema -- acrs-20231231 XSD 167K 89: JSON XBRL Instance as JSON Data -- MetaLinks 543± 818K 90: ZIP XBRL Zipped Folder -- 0001558370-24-001753-xbrl Zip 593K
Exhibit 97.1
ACLARIS THERAPEUTICS, INC.
INCENTIVE COMPENSATION RECOUPMENT POLICY
1.INTRODUCTION
The Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of Aclaris Therapeutics, Inc., a Delaware corporation (the “Company”), and the Board have determined that it is in the best interests of the Company and its stockholders to adopt this Incentive Compensation Recoupment Policy (this “Policy”) providing for the Company’s recoupment of Recoverable Incentive Compensation that is received by Covered Officers of the Company under certain circumstances. Certain capitalized terms used in this Policy have the meanings given to such terms in Section 3 below.
This Policy is designed to comply with, and shall be interpreted to be consistent with, Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder (“Rule 10D-1”) and Nasdaq Listing Rule 5608 (the “Listing Standards”).
2.EFFECTIVE DATE
This Policy shall apply to all Incentive Compensation that is received by a Covered Officer on or after October 2, 2023 (the “Effective Date”). Incentive Compensation is deemed “received” in the Company’s fiscal period in which the Financial Reporting Measure specified in the Incentive Compensation award is attained, even if the payment or grant of such Incentive Compensation occurs after the end of that period.
3.DEFINITIONS
“Accounting Restatement” means an accounting restatement that the Company is required to prepare due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.
“Accounting Restatement Date” means the earlier to occur of (a) the date that the Board, a committee of the Board authorized to take such action, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement, or (b) the date that a court, regulator or other legally authorized body directs the Company to prepare an Accounting Restatement.
“Administrator” means the Compensation Committee or, in the absence of such committee, the Board.
“Code” means the U.S. Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.
“Covered Officer” means each current and former Executive Officer.
“Exchange” means the Nasdaq Stock Market.
“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.
“Executive Officer” means the Company’s president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer who performs a policy-making function, or any other person who performs similar policy-making functions for the Company. Executive officers of the Company’s parent(s) or subsidiaries are deemed executive officers of the Company if they perform such policy-making functions for the Company. Policy-making function is not intended to include policy-making functions that are not significant. Identification of an executive officer for purposes of this Policy would include at a minimum executive officers identified pursuant to Item 401(b) of Regulation S-K promulgated under the Exchange Act.
“Financial Reporting Measures” means measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures derived wholly or in part from such measures, including Company stock price and total shareholder return (“TSR”). A measure need not be presented in the Company’s financial statements or included in a filing with the SEC in order to be a Financial Reporting Measure.
“Incentive Compensation” means any compensation that is granted, earned or vested based wholly or in part upon the attainment of a Financial Reporting Measure.
“Lookback Period” means the three completed fiscal years immediately preceding the Accounting Restatement Date, as well as any transition period (resulting from a change in the Company’s fiscal year) within or immediately following those three completed fiscal years (except that a transition period of at least nine months shall count as a completed fiscal year). Notwithstanding the foregoing, the Lookback Period shall not include fiscal years completed prior to the Effective Date.
“Recoverable Incentive Compensation” means Incentive Compensation received by a Covered Officer during the Lookback Period that exceeds the amount of Incentive Compensation that would have been received had such amount been determined based on the Accounting Restatement, computed without regard to any taxes paid (i.e., on a gross basis without regarding to tax withholdings and other deductions). For any compensation plans or programs that take into account Incentive Compensation, the amount of Recoverable Incentive Compensation for purposes of this Policy shall include, without limitation, the amount contributed to any notional account based on Recoverable Incentive Compensation and any earnings to date on that notional amount. For any Incentive Compensation that is based on stock price or TSR, where the Recoverable Incentive Compensation is not subject to mathematical recalculation directly from the information in an Accounting Restatement, the Administrator will determine the amount of Recoverable Incentive Compensation based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or TSR upon which the Incentive Compensation was received. The Company shall maintain documentation of the determination of that reasonable estimate and provide such documentation to the Exchange in accordance with the Listing Standards.
“SEC” means the U.S. Securities and Exchange Commission.
4.RECOUPMENT
(a)Applicability of Policy. This Policy applies to Incentive Compensation received by a Covered Officer (i) after beginning services as an Executive Officer, (ii) who served as an Executive Officer at any time during the performance period for such Incentive Compensation, (iii) while the Company had a class of securities listed on a national securities exchange or a national securities association, and (iv) during the Lookback Period.
(b)Recoupment Generally. Pursuant to the provisions of this Policy, if there is an
2
Accounting Restatement, the Company must reasonably promptly recoup the full amount of the Recoverable Incentive Compensation, unless the conditions of one or more subsections of Section 4(c) of this Policy are met and the Compensation Committee, or, if such committee does not consist solely of independent directors, a majority of the independent directors serving on the Board, has made a determination that recoupment would be impracticable. Recoupment is required regardless of whether the Covered Officer engaged in any misconduct and regardless of fault, and the Company’s obligation to recoup Recoverable Incentive Compensation is not dependent on whether or when any restated financial statements are filed.
(c)Impracticability of Recovery. Recoupment may be determined to be impracticable if, and only if:
(i)the direct expense paid to a third party to assist in enforcing this Policy would exceed the amount of the applicable Recoverable Incentive Compensation; provided that, before concluding that it would be impracticable to recover any amount of Recoverable Incentive Compensation based on expense of enforcement, the Company shall make a reasonable attempt to recover such Recoverable Incentive Compensation, document such reasonable attempt(s) to recover, and provide that documentation to the Exchange in accordance with the Listing Standards; or
(ii)recoupment of the applicable Recoverable Incentive Compensation would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Code Section 401(a)(13) or Code Section 411(a) and regulations thereunder.
(d)Sources of Recoupment. To the extent permitted by applicable law, the Administrator shall, in its sole discretion, determine the timing and method for recouping Recoverable Incentive Compensation hereunder, provided that such recoupment is undertaken reasonably promptly. The Administrator may, in its discretion, seek recoupment from a Covered Officer from any of the following sources or a combination thereof, whether the applicable compensation was approved, awarded, granted, payable or paid to the Covered Officer prior to, on or after the Effective Date: (i) direct repayment of Recoverable Incentive Compensation previously paid to the Covered Officer; (ii) cancelling prior cash or equity-based awards (whether vested or unvested and whether paid or unpaid); (iii) cancelling or offsetting against any planned future cash or equity-based awards; (iv) forfeiture of deferred compensation, subject to compliance with Code Section 409A; and (v) any other method authorized by applicable law or contract. Subject to compliance with any applicable law, the Administrator may effectuate recoupment under this Policy from any amount otherwise payable to the Covered Officer, including amounts payable to such individual under any otherwise applicable Company plan or program, e.g., base salary, bonuses or commissions and compensation previously deferred by the Covered Officer. The Administrator need not utilize the same method of recovery for all Covered Officers or with respect to all types of Recoverable Incentive Compensation.
(e)No Indemnification of Covered Officers. Notwithstanding any indemnification agreement, applicable insurance policy or any other agreement or provision of the Company’s certificate of incorporation or bylaws to the contrary, no Covered Officer shall be entitled to indemnification or advancement of expenses in connection with any enforcement of this Policy by the Company, including paying or reimbursing such Covered Officer for insurance premiums to cover potential obligations to the Company under this Policy.
(f)Indemnification of Administrator. Any members of the Administrator, and any other members of the Board who assist in the administration of this Policy, shall not be personally liable for any action, determination or interpretation made with respect to this Policy and shall be indemnified by the
3
Company to the fullest extent under applicable law and Company policy with respect to any such action, determination or interpretation. The foregoing sentence shall not limit any other rights to indemnification of the members of the Board under applicable law or Company policy.
5.ADMINISTRATION
Except as specifically set forth herein, this Policy shall be administered by the Administrator. The Administrator shall have full and final authority to make any and all determinations required under this Policy. Any determination by the Administrator with respect to this Policy shall be final, conclusive and binding on all interested parties and need not be uniform with respect to each individual covered by this Policy. In carrying out the administration of this Policy, the Administrator is authorized and directed to consult with the full Board or such other committees of the Board as may be necessary or appropriate as to matters within the scope of such other committee’s responsibility and authority. Subject to applicable law, the Administrator may authorize and empower any officer or employee of the Company to take any and all actions that the Administrator, in its sole discretion, deems necessary or appropriate to carry out the purpose and intent of this Policy (other than with respect to any recovery under this Policy involving such officer or employee).
6.SEVERABILITY
If any provision of this Policy or the application of any such provision to a Covered Officer shall be adjudicated to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Policy, and the invalid, illegal or unenforceable provisions shall be deemed amended to the minimum extent necessary to render any such provision or application enforceable.
7.NO IMPAIRMENT OF OTHER REMEDIES
Nothing contained in this Policy, and no recoupment or recovery as contemplated herein, shall limit any claims, damages or other legal remedies the Company or any of its affiliates may have against a Covered Officer arising out of or resulting from any actions or omissions by the Covered Officer. This Policy does not preclude the Company from taking any other action to enforce a Covered Officer’s obligations to the Company, including, without limitation, termination of employment and/or institution of civil proceedings. This Policy is in addition to the requirements of Section 304 of the Sarbanes-Oxley Act of 2002 that are applicable to the Company’s Chief Executive Officer and Chief Financial Officer and to any other compensation recoupment policy and/or similar provisions in any employment, equity plan, equity award, or other individual agreement, to which the Company is a party or which the Company has adopted or may adopt and maintain from time to time.
8.AMENDMENT; TERMINATION
The Administrator may amend, terminate or replace this Policy or any portion of this Policy at any time and from time to time in its sole discretion. The Administrator shall amend this Policy as it deems necessary to comply with applicable law or any Listing Standard.
9.SUCCESSORS
This Policy shall be binding and enforceable against all Covered Officers and, to the extent required by Rule 10D-1 and/or the applicable Listing Standards, their beneficiaries, heirs, executors, administrators or other legal representatives.
4
10.REQUIRED FILINGS
The Company shall make any disclosures and filings with respect to this Policy that are required by law, including as required by the SEC.
* * * * *
5
ACLARIS THERAPEUTICS, INC.
INCENTIVE COMPENSATION RECOUPMENT POLICY
FORM OF EXECUTIVE ACKNOWLEDGMENT
I, the undersigned, agree and acknowledge that I am bound by, and subject to, the Aclaris Therapeutics, Inc. Incentive Compensation Recoupment Policy, as may be amended, restated, supplemented or otherwise modified from time to time (the “Policy”). In the event of any inconsistency between the Policy and the terms of any employment agreement, offer letter or other individual agreement with Aclaris Therapeutics, Inc. (the “Company”) to which I am a party, or the terms of any compensation plan, program or agreement, whether or not written, under which any compensation has been granted, awarded, earned or paid to me, the terms of the Policy shall govern.
In the event that the Administrator (as defined in the Policy) determines that any compensation granted, awarded, earned or paid to me must be forfeited or reimbursed to the Company pursuant to the Policy, I will promptly take any action necessary to effectuate such forfeiture and/or reimbursement. I further agree and acknowledge that I am not entitled to indemnification, and hereby waive any right to advancement of expenses, in connection with any enforcement of the Policy by the Company.
Agreed and Acknowledged:
| | |
| | |
Name: | | |
| | |
Title: | | |
| | |
Date: | | |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 2/27/24 | 8-K | ||
For Period end: | 12/31/23 | |||
10/2/23 | ||||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/25/24 Aclaris Therapeutics, Inc. DEF 14A 6/06/24 11:3.3M Toppan Merrill Bridge/FA |